Publications

BibTex format

@article{Janson:2019:10.1183/23120541.00073-2018,
author = {Janson, C and Accordini, S and Cazzoletti, L and Cerveri, I and Chanoine, S and Corsico, A and Ferreira, DS and Garcia-Aymerich, J and Gislason, D and Nielsen, R and Johannessen, A and Jogi, R and Malinovschi, A and Martinez-Moratalla, Rovira J and Marcon, A and Pin, I and Quint, J and Siroux, V and Almar, E and Bellisario, V and Franklin, KA and Gullón, JA and Holm, M and Heinrich, J and Nowak, D and Sánchez-Ramos, JL and Weyler, JJ and Jarvis, D},
doi = {10.1183/23120541.00073-2018},
journal = {ERJ Open Research},
title = {Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III},
url = {http://dx.doi.org/10.1183/23120541.00073-2018},
volume = {5},
year = {2019}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Asthma often remains uncontrolled, despite the fact that the pharmacological treatment has undergone large changes. We studied changes in the treatment of asthma over a 20-year period and identified factors associated with the regular use of inhaled corticosteroid (ICS) treatment. Changes in the use of medication were determined in 4617 randomly selected subjects, while changes in adults with persistent asthma were analysed in 369 participants. The study compares data from three surveys in 24 centres in 11 countries. The use of ICSs increased from 1.7% to 5.9% in the general population and the regular use of ICSs increased from 19% to 34% among persistent asthmatic subjects. The proportion of asthmatic subjects reporting asthma attacks in the last 12months decreased, while the proportion that had seen a doctor in the last 12months remained unchanged (42%). Subjects with asthma who had experienced attacks or had seen a doctor were more likely to use ICSs on a regular basis. Although ICS use has increased, only one-third of subjects with persistent asthma take ICSs on a regular basis. Less than half had seen a doctor during the last year. This indicates that underuse of ICSs and lack of regular healthcare contacts remains a problem in the management of asthma.
AU  - Janson,C
AU  - Accordini,S
AU  - Cazzoletti,L
AU  - Cerveri,I
AU  - Chanoine,S
AU  - Corsico,A
AU  - Ferreira,DS
AU  - Garcia-Aymerich,J
AU  - Gislason,D
AU  - Nielsen,R
AU  - Johannessen,A
AU  - Jogi,R
AU  - Malinovschi,A
AU  - Martinez-Moratalla,Rovira J
AU  - Marcon,A
AU  - Pin,I
AU  - Quint,J
AU  - Siroux,V
AU  - Almar,E
AU  - Bellisario,V
AU  - Franklin,KA
AU  - Gullón,JA
AU  - Holm,M
AU  - Heinrich,J
AU  - Nowak,D
AU  - Sánchez-Ramos,JL
AU  - Weyler,JJ
AU  - Jarvis,D
DO  - 10.1183/23120541.00073-2018
PY  - 2019///
SN  - 2312-0541
TI  - Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III
T2  - ERJ Open Research
UR  - http://dx.doi.org/10.1183/23120541.00073-2018
UR  - https://www.ncbi.nlm.nih.gov/pubmed/30723731
UR  - http://hdl.handle.net/10044/1/66592
VL  - 5
ER  -

Download

ProfessorJenniferQuint

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)